Global Endowment Management »

Aeglea Biotherapeutics shares owned by Global Endowment Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Global Endowment Management from 13F filings

Historical chart of Global Endowment Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Global Endowment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Global Endowment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $305k 18k 16.76
2025-06-30 $272k 18k 14.97
2025-03-31 $293k 18k 16.14
2024-12-31 $423k 18k 23.28
2024-09-30 $535k 18k 29.41
2024-06-30 $428k 18k 23.51
2024-03-31 $690k 18k 37.93
2023-12-31 $11M 513k 21.52

More positions owned by Global Endowment Management

Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Txo Partners Com Unit (TXO)
J P Morgan Exchange Traded F Betbuld Msci (BBRE)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Ac Asia Etf (AAXJ)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Global Endowment Management

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics